B cells in adult and pediatric lupus - Clinical Trial
Email to Participate
edna.scarlett@duke.edu
What is the Purpose of this Study?
We are doing this study to better understand what causes lupus and how lupus is different in children versus adults.
What is the Condition Being Studied?
Systemic Lupus Erythematosus (Lupus, or SLE)
Who Can Participate in the Study?
To join this study, you must:
- Be 11-18 or 26-50 years old
- Have been diagnosed with SLE (Lupus) in the past 10 years
- Have not been treated with rituximab or cyclophosphamide in the past 2 years
- Have not been treated with belimumab in the past 6 months
- Not have an active infection
- Not have another rheumatologic diagnosis
Age Group
Adults, Children
What is Involved?
If you agree to join this study, you will have only one study visit for a blood test.
Study Details
Full Title
Comparing B cell tolerance checkpoints between pediatric-onset and adult-onset lupus
Principal Investigator
Adolescent Medicine Specialist
Protocol Number
IRB:
PRO00080281
Enrollment Status
Open for Enrollment
Participate
Email edna.scarlett@duke.edu